# Monitoring Analgesic Therapy in Horses: A Practical Guide ## Key Takeaways - Effective analgesic therapy monitoring requires serial assessment of both therapeutic efficacy and potential adverse effects, utilizing structured pain scoring systems (composite or simple descriptive scales) and physiological parameters like heart and respiratory rates. - Gastrointestinal and renal complications are significant risks associated with Non-Steroidal Anti-Inflammatory Drug (NSAID) use, necessitating close monitoring of fecal output, appetite, hydration status, and serum creatinine. - Behavioral responses, gait, weight-bearing, and epidural catheter site integrity are critical indicators for orthopedic pain and procedural complications, respectively, requiring regular, objective evaluation. - Rescue analgesia requirements serve as a direct signal of inadequate baseline pain control, prompting reassessment of drug choice, dose, or route, and guiding decisions for escalating to multimodal therapy. - Documentation of all monitoring parameters, drug administrations, and observed effects is paramount for clinical decision-making, continuity of care, and medicolegal purposes, enabling trend analysis and informed adjustments to the analgesic plan. --- Effective pain management in horses requires more than selecting an appropriate drug and dose. The clinician must establish a monitoring framework that evaluates both therapeutic efficacy and the development of adverse effects. This article provides a practical reference for veterinary students and practitioners on how to monitor analgesic therapy in horses, addressing pain scoring methods, assessment of drug-specific side effects, and adjustment of analgesic plans based on serial evaluations. The guidance is grounded in published clinical guidelines and peer-reviewed evidence, with attention to areas where the evidence base remains limited. Monitoring serves two distinct purposes. First, it determines whether the chosen analgesic regimen is providing adequate pain relief. Second, it detects complications arising from the therapy itself, including gastrointestinal injury, renal impairment, and behavioral changes. Both objectives require systematic, repeatable assessment tools and a clear understanding of the physiological and pharmacological principles that underpin them. This article focuses on the monitoring process itself instead of specific drug protocols, though drug class considerations are discussed where they directly influence monitoring decisions. ## At a Glance | Parameter | What to Monitor | Clinical Relevance | |---|---|---| | Pain score | Serial composite or simple descriptive scores | Tracks analgesic efficacy over time | | Heart rate and respiratory rate | Trends, not single readings | Elevations may indicate inadequate analgesia | | Gastrointestinal status | Fecal output, appetite, borborygmi | NSAID therapy carries risk of right dorsal colitis | | Renal function | Hydration status, urinalysis, serum creatinine | NSAIDs can reduce renal perfusion in dehydrated horses | | Behavioral response | Response to handling, posture, facial expression | Early indicator of breakthrough pain | | Gait and weight-bearing | Lameness score at walk and trot | Objective measure for orthopedic pain | | Epidural catheter site | Swelling, discharge, catheter patency | Catheter-related complications are common | | Rescue analgesia requirement | Frequency and dose of additional agents | Signals inadequate baseline analgesia | ## Physiology of Pain and Analgesic Response Pain perception in horses follows the same general neurophysiological pathways described in other mammals. Nociceptive signals travel from peripheral receptors via A-delta and C fibers to the dorsal horn of the spinal cord, where modulation occurs before transmission to supraspinal centers. The inflammatory response to tissue injury sensitizes peripheral nociceptors, lowering their activation threshold and producing primary hyperalgesia. Central sensitization, driven by sustained nociceptive input, amplifies pain signals and can produce secondary hyperalgesia in uninjured tissue. These mechanisms explain why early, multimodal analgesia is more effective than delayed monotherapy, and why monitoring must begin before the analgesic plan is initiated. The equine pain response includes both physiological and behavioral components. Physiological parameters such as heart rate, respiratory rate, and circulating cortisol concentrations are influenced by many factors beyond pain, including stress, excitement, and handling. Behavioral indicators, including posture, facial expression, and response to palpation, are more specific but require training to apply consistently. The [BEVA primary care clinical guidelines on analgesia](https://pubmed.ncbi.nlm.nih.gov/31657050/) emphasize that analgesic agents should be used only under veterinary control after full patient evaluation, which includes establishing a baseline pain assessment against which treatment response can be measured. ## Pain Scoring Systems Several pain scoring systems have been developed for horses, ranging from simple descriptive scales to composite scoring tools that integrate multiple behavioral and physiological parameters. The choice of system depends on the clinical setting, the nature of the pain, and the training of the observers who will apply it. ### Composite Pain Scales Composite scales assign numerical scores to multiple categories, including posture, weight-bearing, response to palpation, appetite, and interaction with surroundings. The sum of category scores provides a global pain index that can be tracked over time. These systems offer better inter-observer reliability than unstructured clinical judgment, but they require training and are time-consuming to apply. A composite scale is most useful in hospitalized patients where serial assessments by multiple staff members are expected. ### Simple Descriptive and Visual Analogue Scales Simple descriptive scales use a small number of categories, such as no pain, mild pain, moderate pain, and severe pain. Visual analogue scales require the observer to mark a point on a continuous line representing the range from no pain to worst possible pain. Both methods are quick and require minimal training, but they sacrifice sensitivity and are more susceptible to observer bias. They are appropriate for rapid serial assessments in ambulatory practice where a full composite score is impractical. ### Laminitis-Specific Assessment Chronic laminitis presents particular monitoring challenges because the pain is persistent, often severe, and complicated by the mechanical forces of weight-bearing on compromised hoof structures. A pain scoring technique developed specifically for laminitis cases has been described, incorporating assessment of weight distribution, willingness to move, and response to hoof testers. This approach recognizes that laminitic pain has neuropathic components that may respond differently to analgesic therapy than acute inflammatory pain. The [review of neuropathic pain management in chronic laminitis](https://pubmed.ncbi.nlm.nih.gov/20699178/) presents this scoring method as a tool for quantifying pain and monitoring responses to treatment in affected horses. ## Physiological Monitoring Physiological parameters provide supporting evidence of analgesic adequacy but must be interpreted cautiously. Heart rate and respiratory rate are influenced by excitement, environmental temperature, and handling stress. A single elevated reading does not confirm inadequate analgesia, and a normal reading does not exclude significant pain. Trends over time, particularly in hospitalized patients, are more informative than isolated measurements. Serial assessment of these parameters should be paired with behavioral observation. A horse that is quiet, eating, and interacting normally with stable vital parameters is likely to be comfortable. A horse with progressive tachycardia, tachypnoea, and deteriorating demeanour despite analgesic therapy requires reassessment of both the pain diagnosis and the analgesic plan. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides reference ranges for equine vital parameters and guidance on their interpretation in clinical contexts. ## Monitoring Adverse Effects All analgesic drug classes carry the potential for adverse effects, and monitoring must include surveillance for these complications alongside assessment of efficacy. The [BEVA primary care clinical guidelines](https://pubmed.ncbi.nlm.nih.gov/31657050/) note the risk of adverse events across all classes of analgesic agents and recommend their use only under veterinary supervision with full patient evaluation. ### Gastrointestinal Effects Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis. Prostaglandins maintain gastric mucosal integrity and renal perfusion, so their suppression can lead to gastric ulceration, right dorsal colitis, and renal injury. Monitoring for gastrointestinal complications includes daily assessment of appetite, fecal output and consistency, and abdominal auscultation. Right dorsal colitis may present with mild colic, diarrhea, or hypoalbuminaemia, and should be suspected in any horse receiving NSAIDs that develops these signs. ### Renal Effects Renal prostaglandins maintain afferent arteriolar dilation during periods of reduced renal perfusion. Horses that are dehydrated, hypovolemic, or hypotensive are at increased risk of NSAID-induced renal injury. Monitoring includes assessment of hydration status, urine output, and serum creatinine concentration in patients receiving prolonged NSAID therapy or those with concurrent risk factors. ### Epidural Catheter Complications Caudal epidural catheterization is used increasingly for multimodal analgesia in hospitalized horses, particularly for orthopedic conditions. A retrospective study of 48 horses with 62 epidural catheters reported complications in 74.2% of catheters, though most were classified as mild or moderate. Exaggerated physiologic responses were the most frequently observed complication, and 52.1% of horses survived to discharge. Monitoring of epidural catheters should include daily inspection of the catheter site for swelling, discharge, or dislodgement, assessment of hindlimb motor function, and evaluation of whether the expected analgesic effect is being achieved. The [descriptive study of caudal epidural catheterization](https://pubmed.ncbi.nlm.nih.gov/36387394/) provides detailed characterization of the complications encountered and their management. ## Adjusting the Analgesic Plan Monitoring data should drive therapeutic decisions. A rising pain score or increasing rescue analgesic requirement indicates that the current regimen is inadequate, prompting reassessment of the pain source, consideration of dose adjustment, or addition of a different drug class. A stable or falling pain score with no rescue requirements supports continuation of the current plan. The development of adverse effects requires weighing the severity of the complication against the analgesic benefit, and may necessitate dose reduction, drug rotation, or addition of gastroprotective therapy. The evidence base for specific monitoring protocols is limited. The [BEVA guidelines](https://pubmed.ncbi.nlm.nih.gov/31657050/) provide recommendations for analgesic selection in specific clinical scenarios but do not prescribe a universal monitoring schedule. Clinicians should adapt their monitoring intensity to the severity of pain, the drugs used, and the patient's concurrent disease status. ## Documentation and Record Keeping Analgesic monitoring generates data that must be captured systematically to support clinical decisions. A standardized record should include the pain score at each assessment, the time relative to drug administration, physiological variables, and any observed adverse effects. The scoring system used should be named in the record, since scores from different instruments are not interchangeable. Serial scores are more informative than isolated values, and trends over time should drive adjustments to the analgesic plan. Record the route, dose, and time of each analgesic administration, along with the person performing the assessment. This allows the response to a specific intervention to be evaluated. For example, a rising pain score two hours after a dose of a non-steroidal anti-inflammatory drug (NSAID) suggests either inadequate dosing, drug selection that does not match the pain type, or progression of the underlying lesion. A falling score supports continuation of the current plan. Documentation also serves a medicolegal function. Records that demonstrate regular pain assessment, a defined escalation pathway, and timely response to deteriorating scores provide evidence of appropriate care. The [AVMA professional practice resources](https://www.avma.org/resources-tools) emphasize the importance of maintaining clinical records that support treatment decisions and client communication. ## Monitoring Parameters and Their Interpretation The table below summarizes the parameters used to monitor analgesic therapy, what each detects, and the clinical action indicated by an abnormal finding. | Parameter | What It Detects | Abnormal Finding | Clinical Action | |---|---|---|---| | Composite pain score | Global pain severity | Rising score despite analgesia | Reassess drug choice, dose, or route | | Simple descriptive scale | Pain category change | Shift from mild to moderate | Increase monitoring frequency | | Heart rate | Autonomic activation, visceral pain | Persistent tachycardia | Evaluate for drug failure or deterioration | | Respiratory rate | Thoracic pain, metabolic disturbance | Tachypnoea without exertion | Consider pulmonary or abdominal pathology | | Gastrointestinal auscultation | Ileus, NSAID toxicity | Absent borborygmi | Withhold NSAIDs, assess for colitis | | Fecal output | Gastrointestinal motility | Reduced or absent feces | Initiate motility support, review analgesia | | Packed cell volume and total protein | Hydration status, protein loss | Rising PCV with low protein | Fluid therapy, reassess NSAID safety | | Creatinine and urea | Renal perfusion, nephrotoxicity | Rising creatinine | Discontinue NSAIDs, restore perfusion | | Mucous membrane color and capillary refill | Perfusion, endotoxaemia | Toxic membranes, prolonged refill | Aggressive resuscitation, reconsider NSAIDs | | Lameness score | Orthopedic pain response | No improvement after 48 hours | Reconsider diagnosis, add multimodal agents | | Catheter site inspection | Epidural catheter complications | Swelling, discharge, dislodgement | Remove or replace catheter | ## Decision Points in the Monitoring Sequence The monitoring sequence follows a defined logic. Assess pain before analgesic administration to establish a baseline. Reassess at the expected peak effect of the drug, then at intervals appropriate to the drug's duration of action. For NSAIDs, this typically means assessment every 12 to 24 hours. For opioids with shorter duration, more frequent assessment is required. The first decision point occurs when the pain score fails to improve by a clinically meaningful margin. The [BEVA primary care clinical guidelines on analgesia](https://pubmed.ncbi.nlm.nih.gov/31657050/) note that different drugs provide different levels of analgesia for different pain types. Phenylbutazone is considered superior to meloxicam and firocoxib for hoof pain, while flunixin and firocoxib are more effective for colic pain. If the chosen drug does not match the pain type, switching to a more appropriate agent is indicated before adding further drugs. The second decision point involves adverse effects. Gastrointestinal signs, reduced fecal output, or rising renal parameters mandate NSAID dose reduction or discontinuation. The guidelines emphasize that all analgesic classes carry risk of adverse events and should be used only under veterinary control after full patient evaluation. The third decision point concerns multimodal therapy. If a single agent provides inadequate analgesia, adding a second drug class is preferable to increasing the dose of the first beyond label recommendations. This is particularly relevant in laminitis, where [neuropathic pain mechanisms in chronic laminitis](https://pubmed.ncbi.nlm.nih.gov/20699178/) may not respond to conventional NSAIDs alone. ## Equipment and Technique Considerations Pain scoring requires no specialised equipment beyond a printed or electronic scoring sheet. Physiological monitoring requires a stethoscope, thermometer, and access to hematology and biochemistry analysis. For hospitalized patients, a weigh scale or weight tape is essential, since analgesic doses are weight-based and underdosing is a common cause of apparent drug failure. Epidural catheter monitoring requires specific equipment and technique. The [descriptive study of caudal epidural catheterization in 48 hospitalized horses](https://pubmed.ncbi.nlm.nih.gov/36387394/) reported complications in 74.2% of catheters, with exaggerated physiologic responses observed most frequently. Catheter site inspection should occur at least daily, with assessment for swelling, discharge, or dislodgement. The catheter should be labelled clearly to prevent accidental administration of drugs not intended for the epidural space. For field practice, where laboratory access may be limited, monitoring relies more heavily on physical examination findings. Heart rate, mucous membrane color, gastrointestinal auscultation, and fecal output can all be assessed without laboratory support. If a horse requires prolonged NSAID therapy in the field, the owner should be instructed to monitor appetite, water intake, and fecal production, and to report any reduction promptly. ## Species and Production System Variations Monitoring intensity should be adjusted to the setting. Hospitalized horses can be assessed multiple times daily with laboratory support. Ambulatory cases require a monitoring plan that the owner can execute, with clear instructions on when to call the veterinarian. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on examination findings and their interpretation. Breed and temperament influence pain scoring. Some horses mask pain behaviorally, particularly in the presence of unfamiliar handlers. A horse that is quiet and withdrawn may be in more pain than one that is overtly agitated. Pain scores should be interpreted in the context of the individual horse's baseline behavior, which may require input from the owner or regular handler. Production systems also matter. Horses kept at pasture may show different pain behaviors than stalled horses. A laminitic horse at pasture may stand at the fence line or shift weight frequently, while the same horse stalled may lie down more often. The monitoring plan should account for the horse's environment and the observer's ability to detect changes. ## Escalation and De-escalation Frameworks Escalation of analgesia follows a stepwise approach. If a single NSAID provides inadequate relief, the first step is to verify that the drug, dose, and dosing interval are appropriate for the pain type. The BEVA guidelines provide specific recommendations for drug selection based on pain source. If the drug is appropriate but ineffective, adding an opioid or other adjunct is the next step. De-escalation should be equally deliberate. When pain scores consistently fall below the treatment threshold, the analgesic plan should be simplified. Reduce one drug at a time, starting with the most recently added agent. Monitor for 24 to 48 hours after each reduction before further changes. Rapid withdrawal of analgesia can precipitate rebound pain that is more difficult to control than the original pain. The decision to discontinue analgesia entirely should be based on sustained low pain scores, normal physiological parameters, and evidence of resolving pathology. In chronic conditions such as laminitis, complete discontinuation may not be achievable, and the goal shifts to maintaining the lowest effective dose. The [neuropathic pain review in chronic laminitis](https://pubmed.ncbi.nlm.nih.gov/20699178/) describes pain scoring techniques that help quantify pain and monitor responses to treatment over extended periods. ## Recognized Complications and Early Detection Analgesic therapy in horses fails through two distinct mechanisms: inadequate pain control and drug-related adverse events. Both require active surveillance instead of passive expectation. Gastrointestinal injury remains the most clinically significant complication of NSAID therapy. Early indicators include reduced fecal output, changes in fecal consistency, inappetence, and mild colic signs. These signs often precede overt protein loss or endotoxaemia by 24 to 48 hours. Serial assessment of mucous membrane color, capillary refill time, and fecal character should be performed at least twice daily in hospitalized horses receiving NSAIDs. A falling packed cell volume with falling total protein suggests gastrointestinal protein loss and warrants immediate drug withdrawal. Renal effects develop more insidiously. Horses receiving NSAIDs during periods of hypovolemia, endotoxaemia, or general anesthesia are at greatest risk. Monitoring urine output, urine specific gravity, and serial creatinine concentrations identifies early dysfunction. A rising creatinine with isosthenuria indicates tubular injury instead of prerenal azotaemia. Horses with colic receiving flunixin are particularly susceptible, and the [BEVA primary care clinical guidelines on analgesia](https://pubmed.ncbi.nlm.nih.gov/31657050/) emphasize that all analgesic classes carry adverse event risk requiring veterinary oversight. Epidural catheter complications occur frequently. In a retrospective series of 48 hospitalized horses, complications were documented for 74.2% of catheters, although most were mild or moderate, with exaggerated physiologic responses observed most commonly. Catheter site swelling, discharge, or ascending infection should be checked daily. Loss of hindlimb motor function beyond the expected dermatomal block, urinary retention, or progressive ataxia demands immediate reassessment of drug selection and catheter position. Opioid-related excitation, ileus, and reduced gastrointestinal motility are dose-dependent and more pronounced in pain-free horses. Sedation level, fecal output, and borborygmi should be recorded at each assessment. ## Common Errors and Corrective Action Less experienced clinicians frequently rely on a single pain score instead of a composite assessment. A horse may show minimal facial expression change yet exhibit marked reluctance to bear weight. The corrective action is to use a validated composite scale alongside physiological parameters and to record all three at fixed intervals. A second error is treating the pain score instead of the horse. Escalating analgesia in response to a single elevated score without reassessing the underlying lesion risks masking surgical deterioration. Re-evaluate the primary problem before increasing drug dose. Third, clinicians often discontinue NSAIDs abruptly when gastrointestinal signs appear, without providing alternative analgesia. This leaves the horse in pain while the original condition resolves. Replace the NSAID with an alternative class while managing the gastrointestinal complication. Fourth, students and new graduates frequently underestimate the duration of analgesia required. The [BEVA guidelines](https://pubmed.ncbi.nlm.nih.gov/31657050/) recommend continuation of analgesia for three days following routine castration, and longer courses are often needed after orthopedic surgery. Premature cessation is a common cause of apparent analgesic failure. ## Limitations of Current Evidence The equine analgesia literature contains few large prospective trials. Most recommendations derive from small studies, extrapolation from other species, or expert consensus. The [BEVA guidelines](https://pubmed.ncbi.nlm.nih.gov/31657050/) used a modified GRADE framework and still found moderate or low certainty for many recommendations, including the comparative efficacy of different NSAIDs for joint pain. Expert opinion diverges on several practical points. Whether to use opioids systemically in horses with colic remains contested, with concerns about ileus balanced against analgesic benefit. The role of multimodal therapy in laminitis is similarly debated. The [review of neuropathic pain management in chronic laminitis](https://pubmed.ncbi.nlm.nih.gov/20699178/) presents a mechanism-based approach to pain therapy and a pain scoring technique for monitoring response, but acknowledges that the underlying pain mechanisms in laminitis are incompletely understood. Evidence for epidural analgesia is largely descriptive. The [caudal epidural catheterization study](https://pubmed.ncbi.nlm.nih.gov/36387394/) reports outcomes and complications but cannot establish comparative efficacy against other routes. Clinicians should recognize that absence of evidence is not evidence of absence, particularly for rare complications such as catheter-related infection or neurological injury. ## Referral, Consultation, and Reporting Referral is warranted when pain remains refractory to escalating doses of standard analgesics, when laminitis progresses despite aggressive therapy, or when complications such as acute kidney injury or severe gastrointestinal ulceration develop. Specialist equine hospitals offer advanced diagnostic imaging, continuous monitoring, and interventional analgesic techniques that are unavailable in ambulatory practice. Laboratory involvement is indicated for serial creatinine monitoring in horses receiving prolonged NSAID therapy, for fecal occult blood or albumin testing when gastrointestinal protein loss is suspected, and for cytology and culture of epidural catheter sites when infection is considered. Regulatory reporting obligations vary by jurisdiction. Suspected adverse drug reactions should be reported to the relevant national pharmacovigilance scheme. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address welfare and trade considerations that may apply when analgesic use affects food-producing horses. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional obligations regarding controlled substance use and adverse event reporting in the United States. | Observation | Likely Cause | Discriminating Check | |---|---|---| | Reduced fecal output, mild colic | NSAID gastrointestinal injury | Fecal occult blood, albumin, abdominal ultrasound | | Rising creatinine, isosthenuria | NSAID renal injury | Urinalysis, urine output, hydration status | | Hindlimb weakness after epidural | Excessive block or catheter migration | Neurological examination, catheter position check | | Persistent pain despite analgesia | Inadequate dose, wrong drug class, or surgical deterioration | Re-score pain, reassess primary lesion, consider referral | | Excitation or agitation | Opioid effect in pain-free horse | Reduce dose, reassess pain score, consider alternative class | ## Frequently Asked Questions ### How do I monitor analgesia when a formal pain scoring system is not available? Use a structured but simplified approach. Record a baseline for each parameter you can assess reliably, then track changes over time. Heart rate, respiratory rate, appetite, fecal output, and willingness to move in the stall provide a practical minimum dataset. Assign a simple numeric score for demeanour and for lameness at the walk. Reassess at consistent intervals, ideally every 4 to 6 hours for hospitalized horses. The [BEVA primary care clinical guidelines](https://pubmed.ncbi.nlm.nih.gov/31657050/) emphasize that systematic assessment, even with basic tools, outperforms unstructured impression. Document the parameters you used so serial comparisons remain valid. If a horse appears comfortable by one measure but deteriorates in another, trust the more specific sign and escalate monitoring frequency. ### What should I do when a horse shows signs of pain despite an apparently adequate analgesic plan? Reassess the horse before changing drugs. Check catheter patency, infusion pump function, and drug administration records. Re-evaluate the pain score using the same scale as the baseline assessment. Consider whether the pain is somatic, visceral, or neuropathic, since each responds differently to drug classes. The [review of neuropathic pain management in chronic laminitis](https://pubmed.ncbi.nlm.nih.gov/20699178/) notes that maladaptive pain mechanisms can dominate in chronic conditions and may require different therapeutic approaches than acute nociceptive pain. If the current plan appears correctly administered and the pain is worsening, escalate to the next step in your analgesic ladder instead of repeating the same drug. Re-examine the horse for new or progressing lesions, including surgical site complications or undiagnosed concurrent disease. ### How do I monitor epidural analgesia in a horse that is also receiving systemic analgesics? Separate the contributions of each route by assessing regional effects. Test perineal and hindlimb sensation, tail tone, and anal sphincter function at regular intervals. Document the response to epidural therapy separately from systemic effects. In a [descriptive study of caudal epidural catheterization in hospitalized horses](https://pubmed.ncbi.nlm.nih.gov/36387394/), complications were documented for most catheters, though most were mild or moderate. Exaggerated physiologic responses were the most frequent complication type. Monitor for catheter dislodgement, local infection at the exit site, and ascending spinal infection. Assess hindlimb weakness or ataxia that might indicate excessive blockade. If systemic analgesics are reduced, do so gradually while observing whether regional analgesia alone maintains comfort. Record both routes in the treatment log so adjustments to one are made with knowledge of the other. ### What monitoring adjustments are needed for horses with renal or hepatic disease? Establish baseline renal and hepatic values before starting therapy and repeat them at intervals appropriate to the drug and the disease severity. For NSAIDs, monitor creatinine, urea, and electrolytes, and assess urine output and urine specific gravity. Dehydrated horses or those with reduced renal perfusion are at higher risk of adverse effects. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on recognizing drug toxicity and adjusting therapy in compromised patients. For horses with hepatic disease, monitor for signs of reduced drug metabolism, including prolonged sedation or altered behavior. Recheck biochemistry sooner when the disease is progressive or when multiple drugs are used concurrently. If renal function deteriorates, discontinue the suspected drug and reassess the analgesic plan instead of simply reducing the dose. ### How should I document analgesic monitoring to support clinical decisions and continuity of care? Record the pain score, the scale used, physiological parameters, and the assessor's identity at each time point. Note any drug administration, dose changes, and the reason for the change. Document adverse effects observed and the action taken. This record supports clinical decisions when different clinicians assess the same horse across shifts. The [AVMA practice resources](https://www.avma.org/resources-tools) emphasize that thorough medical records support patient safety and professional accountability. Include a plan for the next assessment interval so monitoring continues without gaps. If the horse is discharged on analgesics, document the monitoring instructions given to the owner and the planned recheck date. Clear records also support communication with referral centers if the case is transferred. ### How do I monitor analgesic efficacy in a horse that cannot be safely handled for detailed assessment? Prioritize observation from a distance before any handling. Assess posture, weight bearing, ear position, facial expression, and response to approach. Appetite and interest in the environment provide useful information without physical contact. If handling is required, use the minimum restraint needed and assess the horse before and after the procedure. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) recognize that welfare assessment must be feasible under field conditions. For fractious or dangerous horses, remote observation may be the only safe option. Document the limitations of the assessment and note that the pain score reflects observable behavior only. Consider whether sedation for examination confounds the pain assessment and record this in the notes. ## Related Clinical & Scientific Guides * [Hypersensitivity Reactions: Types and Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/hypersensitivity-reactions-types-and-mechanisms) * [Therapeutic Decision-Making for Respiratory Infections in Cattle](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-making-respiratory-infections-cattle) * [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary) ## References and Further Reading - [BEVA primary care clinical guidelines: Analgesia.](https://pubmed.ncbi.nlm.nih.gov/31657050/). 2020. - [Neuropathic pain management in chronic laminitis.](https://pubmed.ncbi.nlm.nih.gov/20699178/). 2010. - [Caudal epidural catheterization for pain management in 48 hospitalized horses: A descriptive study of demographics, complications, and outcomes.](https://pubmed.ncbi.nlm.nih.gov/36387394/). 2022. - [Davis-Thompson Foundation Veterinary Pathology Resources](https://www.davisthompsonfoundation.org/). Davis-Thompson Foundation. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. - [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH. ## Related Articles - [Monitoring Antifungal Therapy in Horses: Efficacy and Safety](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-antifungal-therapy-horses-efficacy-safety) - [Monitoring Corticosteroid Therapy in Veterinary Dermatology](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-corticosteroid-therapy-veterinary-dermatology) - [Monitoring Immunosuppressive Therapy in Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-immunosuppressive-therapy-veterinary) - [Monitoring Endocrine Therapy in Veterinary Patients: Insulin and Beyond](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-endocrine-therapy-veterinary-insulin) - [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.